1887

Journal of General Virology header logo

Volume 74, Issue 8

Restricted replication of respiratory syncytial virus in human alveolar macrophages Free

Abstract

The cellular factors that regulate infection and replication of respiratory syncytial virus (RSV) in human alveolar macrophages were examined. RSV-exposed alveolar macrophages demonstrated a time-dependent expression of viral glycoproteins, maximal by 24 h post-infection resulting in infection of approx. 38% of the cells. Essentially all (33%) of these freshly isolated alveolar macrophages replicated RSV as shown by infectious centre assays. This RSV-permissive subpopulation of alveolar macrophages consisted primarily of major histocompatibility class II-expressing cells as determined by fluorescence-activated cell sorting. Reinfection of alveolar macrophages did not significantly alter the number of cells infected or capable of replicating RSV. However, differentiation of alveolar macrophages prior to infection resulted in a significant ( < 0·05), time-dependent decrease (approx. sevenfold) in the number of cells that replicated virus. The mechanism by which cellular differentiation restricted RSV replication is unknown. Production of defective interfering particles did not account for this decrease. Alveolar macrophages infected with RSV produce a variety of cytokines potentially contributing to this restricted viral replication. Pretreatment with several of these cytokines did not affect viral infection or replication. However, tumour necrosis factor (TNF) significantly ( < 0·05) decreased viral replication but only by 30 to 60%. Thus RSV replication is reduced by differentiation of alveolar macrophages and, to a lesser degree, by pretreatment with TNF.

  • Received:
  • Accepted:
  • Published Online:
© Society for General Microbiology 1993
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-8-1527
1993-08-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/8/JV0740081527.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-8-1527&mimeType=html&fmt=ahah

References

  1. Aherne W, Bird T, Court SDM, Gardner PS, McQuillin J. 1970; Pathological changes in virus infections of the lower respiratory tract in children.. Journal of Clinical Pathology 23:7–18
     [Google Scholar]
  2. Ahrens PB, Besancjon F, Memet S, Ankel H. 1990; Tumour necrosis factor enhances induction by β-interferon of a ubiquitin cross-reactive protein.. Journal of General Virology 71:1675–1682
     [Google Scholar]
  3. Becker S, Quay J, Soukup J. 1991; Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages.. Journal of Immunology 147:4307–4312
     [Google Scholar]
  4. Becker S, Soukup J, Yankaskas JR. 1992; Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages.. American Journal of Respiratory Cell and Molecular Biology 6:369–374
     [Google Scholar]
  5. Beutler B, Cerami A. 1989; The biology of cachectin/TNF-a primary mediator of host defense.. Annual Review of Immunology 7:625–655
     [Google Scholar]
  6. Braquet P, Paubert-Braquet M, Bourgain RH, Bussolino F, Hosford D. 1989; PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection.. Journal of Lipid Mediators 1:75–112
     [Google Scholar]
  7. Chandler DB, Fulmer JD. 1987; Prostaglandin synthesis and release by sub-populations of rat alveolar macrophages.. Journal of Immunology 139:893–898
     [Google Scholar]
  8. Chayt KJ, Harper ME, Marselle LM, Lewin EB, Rose RM, Oleske JM, Epstein LG, Wong-Staal F, Gallo RC. 1986; Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement.. Journal of the American Medical Association 256:2356–2359
     [Google Scholar]
  9. Dinarello CA. 1989; Interleukin-1 and its biologically related cytokines.. Advances in Immunology 44:153–199
     [Google Scholar]
  10. Elias JA, Schreiber AD, Gustilo K, Chien P, Rossman MD, Lammie PJ, Daniele RP. 1985; Differential interleukin 1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity.. Journal of Immunology 135:3198–3204
     [Google Scholar]
  11. Ferro TJ, Kern JA, Elias JA, Kamoun M, Daniele RP, Rossman MD. 1987; Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen.. American Review of Respiratory Disease 135:682–687
     [Google Scholar]
  12. Gendelman HE, Narayan O, Molineaux S, Clements JE, Ghotbi Z. 1985; Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow.. Proceedings of the National Academy of Sciences, U.S.A. 82:7086–7090
     [Google Scholar]
  13. Inada T, Mims CA. 1984; Mouse la antigens are receptors for lactate dehydrogenase virus.. Nature, London 309:59–61
     [Google Scholar]
  14. Kimman TG, Westenbrink F. 1990; Immunity to human and bovine respiratory syncytial virus.. Archives of Virology 112:1–25
     [Google Scholar]
  15. Krilov LR, Hendry RM, Godfrey E, McIntosh K. 1987; Respiratory virus infection of peripheral blood monocytes: correlation with ageing of cells and interferon production in vitro.. Journal of General Virology 68:1749–1753
     [Google Scholar]
  16. Laude H, Charley B, Gelfi J. 1984; Replication of transmissible gastroenteritis coronavirus (TGEV) in swine alveolar macrophages.. Journal of General Virology 6:327–332
     [Google Scholar]
  17. Leiter EH, Christianson GJ, Serreze DV, Ting AT, Worthen SM. 1989; MHC antigen induction by interferon γ on cultured mouse pancreatic β cells and macrophages.. Journal of Experimental Medicine 170:1243–1262
     [Google Scholar]
  18. Lipscomb MF, Lyons CR, Nunez G, Ball EJ, Stastny P, Vial W, Lem V, Weissler J, Miller LM, Toews GB. 1986; Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction.. Journal of Immunology 136:497–504
     [Google Scholar]
  19. McIntosh K, Chanock RM. 1990; Respiratory syncytial virus.. In Virology, 2nd edn. pp. 1045–1072 Edited by B. N. Fields & D. M. Knipe. New York: Raven Press;
     [Google Scholar]
  20. Mann DL, Read-Connole E, Arthur LO, Robey WG, Wernet P, Shneider EM, Blattner WA, Popovic M. 1988; HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.. Journal of Immunology 141:1131–1136
     [Google Scholar]
  21. Merolla R, Rebert N, Panuska JR. 1992; Replication of respiratory syncytial virus (RSV) in human pulmonary epithelial cells: implications for pathogenesis.. Clinical Research 40:140A–140A
     [Google Scholar]
  22. Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsen H, Kirchner H. 1986; Antiviral effects of recombinant tumour necrosis factor in vitro.. Nature, London 323:816–818
     [Google Scholar]
  23. Midulla F, Huang YT, Gilbert IA, Cirino NM, McFadden ER, Panuska JR. 1989; Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages.. American Review of Respiratory Disease 140:771–777
     [Google Scholar]
  24. Mills J. 1979; Effects of Sendai virus infection on function of cultured mouse alveolar macrophages.. American Review of Respiratory Disease 120:1239–1244
     [Google Scholar]
  25. Morahan PS, Connor JR, Leary KR. 1985; Viruses and the versatile macrophage.. British Medical Bulletin 41:15–21
     [Google Scholar]
  26. Nain M, Hinder F, Gong JH, Schmidt A, Bender A, Sprenger H, Gemsa D. 1990; Tumor necrosis factor-a production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides.. Journal of Immunology 145:1921–1928
     [Google Scholar]
  27. Nash TW, Libby DM, Horwitz MA. 1988; IFN-γ-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila.. Journal of Immunology 140:3978–3981
     [Google Scholar]
  28. Nathan C. 1987; Secretory products of macrophages.. Journal of Clinical Investigation 79:319–326
     [Google Scholar]
  29. Neilson KA, Yunis EJ. 1990; Demonstration of respiratory syncytial virus in an autopsy series.. Pediatric Pathology 10:491–502
     [Google Scholar]
  30. Nicod LP, Lipscomb MF, Weissler JC, Toews GB. 1989; Mononuclear cells from human lung parenchyma support antigen-induced T lymphocyte proliferation.. Journal of Leukocyte Biology 45:336–344
     [Google Scholar]
  31. Panuska JR, Cirino N, Midulla F, Despot JE, McFadden ER, Huang YT. 1990a; Productive infection of isolated human alveolar macrophages by respiratory syncytial virus.. Journal of Clinical Investigation 86:113–119
     [Google Scholar]
  32. Panuska JR, Midulla F, Cirino N, Villani A, Gilbert IA, McFadden ER, Huang YT. 1990b; Virus induced alterations in macrophage production of tumor necrosis factor and prostaglandin E2.. American Journal of Physiology 259:L396–L402
     [Google Scholar]
  33. Panuska JR, Hertz MI, Taraf H, Villani A, Cirino N. 1992; Respiratory syncytial virus infection of alveolar macrophage in adult transplant patients.. American Review of Respiratory Disease 145:934–939
     [Google Scholar]
  34. Parry JE, Shirodaria PV, Pringle CR. 1979; Pneumoviruses: the cell surface of lyrically and persistently infected cells.. Journal of General Virology 44:479–491
     [Google Scholar]
  35. Pringle CR. 1987; Paramyxoviruses and diseases.. In Molecular Basis of Virus Disease pp. 51–90 Edited by W. C. Russell & J. W. Almond.. Cambridge: Cambridge University Press;
     [Google Scholar]
  36. Rich EA, Tweardy DJ, Fujiwara H, Ellner JJ. 1987; Spectrum of immunoregulatory functions and properties of human alveolar macrophages.. American Review of Respiratory Disease 136:258–265
     [Google Scholar]
  37. Roberts NJ, Prill AH, Mann TN. 1986; Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus.. Journal of Experimental Medicine 163:511–519
     [Google Scholar]
  38. Rose RM, Wasserman AS, Weiser WY, Remold HG. 1986; An acidic lymphokine distinct from interferon-}' inhibits the replication of herpes simplex virus in human pulmonary macrophages.. Cellular Immunology 97:397–406
     [Google Scholar]
  39. Rossi GA, Zocchi E, Sacco O, Balbi B, Ravazzoni C, Damiani G. 1986; Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions.. American Review of Respiratory Disease 133:76–82
     [Google Scholar]
  40. Salkind AR, McCarthy DO, Nichols JE, Domurat FM, Walsh EE, Roberts NJ. 1991; Interleukin-1-inhibitor activity induced by respiratory syncytial virus: abrogation of virus-specific and alternate human lymphocyte proliferative responses.. Journal of Infectious Diseases 163:71–77
     [Google Scholar]
  41. Stott EJ, Taylor G. 1985; Respiratory syncytial virus.. Archives of Virology 84:1–52
     [Google Scholar]
  42. Unanue ER, Allen PM. 1987; The basis for the immunoregulatory role of macrophages and other accessory cells.. Science 236:551–557
     [Google Scholar]
  43. Unanue ER, Cerottini JC. 1989; Antigen presentation.. Federation of American Societies for Experimental Biology Journal 3:2496–2502
     [Google Scholar]
  44. Villani A, Cirino NM, Baldi E, Kester M, McFadden ER, Panuska JR. 1991; Respiratory syncytial virus infection of human mononuclear phagocytes stimulates synthesis of plateletactivating factor.. Journal of Biological Chemistry 266:5472–5479
     [Google Scholar]
  45. Watanabe Y, Jacob CO. 1991; Regulation of MHC of class II antigen expression: opposing effects of tumor necrosis factor-a on IFN-y-induced HLA-DR and la expression depends on the maturation and differentiation stage of the cell.. Journal of Immunology 146:899–905
     [Google Scholar]
  46. Witsell AL, Schook LB. 1992; Tumor necrosis factor a is an autocrine growth regulator during macrophage differentiation.. Proceedings of the National Academy of Sciences, U.S.A. 89:4754–4758
     [Google Scholar]
  47. Wong GH, Goeddel DV. 1986; Tumour necrosis factors α and β inhibit virus replication and synergize with interferons.. Nature, London 323:819–822
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-8-1527
Loading
Restricted replication of respiratory syncytial virus in human alveolar macrophages
J. Gen. Virol. 74, 1527 (1993); https://doi.org/10.1099/0022-1317-74-8-1527
/content/journal/jgv/10.1099/0022-1317-74-8-1527
/content/journal/jgv/10.1099/0022-1317-74-8-1527
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error